Phase I trial of pomalidomide (P) in patients (pts) with relapsed and/or refractory (R/R) Waldenström's macroglobulinemia (WM).
暂无分享,去创建一个
Michael L. Wang | R. Orlowski | S. Neelapu | Sheeba K. Thomas | J. Shah | D. Weber | A. Melendez | Lei Feng
暂无分享,去创建一个
Michael L. Wang | R. Orlowski | S. Neelapu | Sheeba K. Thomas | J. Shah | D. Weber | A. Melendez | Lei Feng